QUT and Swiss medtech company Abionic SA are collaborating to develop rapid, targeted tests for allergies to subtropical grass pollens – tests that could be administered in a GP office.
Understanding the disease
Our biomolecular science researchers are working to improve understanding of the disease process at the molecular level and develop better diagnostics and therapeutics to combat disease.
We're using state-of-the-art technologies to investigate the molecular basis of disease by studying:
- cell and tissue structure
- cell interactions and signalling
- DNA and protein sequences
- systems biology integration.
Our researchers have strength and expertise in:
- cancer biology
- infectious disease
- vaccine development
- stem cell and tissue regeneration research.
Genomics Research Centre
We focus on common chronic human disorders - for example, migraine, high blood pressure and cancer - that have a significant genetic component. Our researchers are working to identify the genes involved in these disorders, leading to better forms of diagnosis and treatment.
Our scientists are experts in gene mapping and the characterisation of gene dysfunction. They translate this information to diagnostic and therapeutic outcomes through techniques like DNA mutation testing and vaccine development.
The centre is funded by national competitive grants and industry, and employs over thirty research staff, including a number of established and long-standing collaborating clinicians.
QUT’s scientific and innovation credentials have been celebrated as part of the 2018 BIO International Convention, with the University signing three key industry agreements, including a major announcement for a promising pre-clinical anti-cancer drug candidate invented by the Cancer and Ageing Research Program (CARP).